These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33242590)

  • 1. Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy.
    Panzitt K; Fickert P; Wagner M
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166017. PubMed ID: 33242590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
    Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
    J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
    Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
    Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.
    Cariello M; Piccinin E; Garcia-Irigoyen O; Sabbà C; Moschetta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1308-1318. PubMed ID: 28965883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
    Molinaro A; Marschall HU
    Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
    Li X; Liu R; Luo L; Yu L; Chen X; Sun L; Wang T; Hylemon PB; Zhou H; Jiang Z; Zhang L
    Arch Toxicol; 2017 Jan; 91(1):481-494. PubMed ID: 27090119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease.
    Zhou T; Kundu D; Robles-Linares J; Meadows V; Sato K; Baiocchi L; Ekser B; Glaser S; Alpini G; Francis H; Kennedy L
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile Acids in Cholestasis and its Treatment.
    Arab JP; Cabrera D; Arrese M
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholemic nephropathy - Historical notes and novel perspectives.
    Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors as drug targets in cholestatic liver diseases.
    Halilbasic E; Baghdasaryan A; Trauner M
    Clin Liver Dis; 2013 May; 17(2):161-89. PubMed ID: 23540496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
    Shi C; Xue W; Han B; Yang F; Yin Y; Hu C
    Eur J Pharmacol; 2019 May; 850():15-22. PubMed ID: 30753863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.
    Petrescu AD; DeMorrow S
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.